BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11691808)

  • 21. [Novel autograft method using positive selection of CD34 stem cells].
    Lambermont M; Pradier O; Delville JP; Quinet C; Bastin G; Marblie S; Capel P; Dupont E; Le Moine F; Gangji D
    Rev Med Brux; 1995 Nov; 16(5):372, 375-8. PubMed ID: 7501915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients.
    Wagner LM; Guichard SM; Burger RA; Morton CL; Straign CM; Ashmun RA; Harris LC; Houghton PJ; Potter PM; Danks MK
    Cancer Res; 2002 Sep; 62(17):5001-7. PubMed ID: 12208753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation.
    Yaniv I; Stein J; Luria D; Cohen IJ; Liberzon E; Manor S; Grunshpan A; Sverdlov Y; Kodman Y; Issakov J; Feinmesser M; Zaizov R; Avigad S
    Bone Marrow Transplant; 2007 May; 39(10):589-94. PubMed ID: 17369866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse.
    Yaniv I; Cohen IJ; Stein J; Zilberstein J; Liberzon E; Atlas O; Grunshpan A; Sverdlov Y; Ash S; Zaizov R; Avigad S
    Pediatr Blood Cancer; 2004 May; 42(5):404-9. PubMed ID: 15049010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards a double controlled conditionally replicative adenovirus for potent and specific melanoma cell kill.
    Gommans WM; Oosterhuis D; Dmitriev I; Schaack J; Curiel DT; Haisma HJ; Rots MG
    J Control Release; 2006 Nov; 116(2):e64-6. PubMed ID: 17718975
    [No Abstract]   [Full Text] [Related]  

  • 26. Purging of peripheral blood stem cell grafts.
    Gee A
    Stem Cells; 1995 Dec; 13 Suppl 3():52-62. PubMed ID: 8747989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
    Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
    Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of hypothermia to autologous stem cell purging.
    Miyagi K; Yamazaki T; Tsujino I; Takahashi N; Koya Y; Masutani M; Sawada U; Horie T
    Cryobiology; 2001 May; 42(3):190-5. PubMed ID: 11578118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
    Ayash LJ; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M
    Hum Gene Ther; 2001 Nov; 12(16):2023-5. PubMed ID: 11727734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
    J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma.
    Wesseling JG; Yamamoto M; Adachi Y; Bosma PJ; van Wijland M; Blackwell JL; Li H; Reynolds PN; Dmitriev I; Vickers SM; Huibregtse K; Curiel DT
    Cancer Gene Ther; 2001 Dec; 8(12):990-6. PubMed ID: 11781662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.
    Suminoe A; Matsuzaki A; Hattori H; Koga Y; Hara T
    Pediatr Transplant; 2009 Sep; 13(6):746-53. PubMed ID: 19067917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo.
    Zhou Z; Reddy K; Guan H; Kleinerman ES
    Mol Cancer Res; 2007 Nov; 5(11):1125-32. PubMed ID: 18025258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.
    Jia SF; Duan X; Worth LL; Guan H; Kleinerman ES
    Cancer Gene Ther; 2006 Oct; 13(10):948-57. PubMed ID: 16763609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts.
    Thirukkumaran CM; Luider JM; Stewart DA; Alain T; Russell JA; Auer IA; Forsyth P; Morris DG
    Bone Marrow Transplant; 2005 Jun; 35(11):1055-64. PubMed ID: 15821774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Megatherapy and stem cell transplantation for Ewing's family of tumors: a critical review of current literature.
    Kalambakas SA; Moore TB; Feig SA
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():83-8. PubMed ID: 15125709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
    Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
    Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
    J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.